Publication: EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity.
dc.contributor.author | Brockow, Knut | |
dc.contributor.author | Ardern-Jones, Michael R | |
dc.contributor.author | Mockenhaupt, Maja | |
dc.contributor.author | Aberer, Werner | |
dc.contributor.author | Barbaud, Annick | |
dc.contributor.author | Caubet, Jean-Christoph | |
dc.contributor.author | Spiewak, Radoslaw | |
dc.contributor.author | Torres, Maria Jose | |
dc.contributor.author | Mortz, Charlotte G | |
dc.date.accessioned | 2023-01-25T10:20:59Z | |
dc.date.available | 2023-01-25T10:20:59Z | |
dc.date.issued | 2019-01-30 | |
dc.description.abstract | Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the most frequently involved organ with a broad spectrum of reaction types. The diagnosis of cutaneous DHRs (CDHR) may be difficult because of multiple differential diagnoses. A correct classification is important for the correct diagnosis and management. With these guidelines, we aim to give precise definitions and provide the background needed for doctors to correctly classify CDHR. | |
dc.description.version | Si | |
dc.identifier.citation | Brockow K, Ardern-Jones MR, Mockenhaupt M, Aberer W, Barbaud A, Caubet JC, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019 Jan;74(1):14-27 | |
dc.identifier.doi | 10.1111/all.13562 | |
dc.identifier.essn | 1398-9995 | |
dc.identifier.pmid | 30028512 | |
dc.identifier.unpaywallURL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/all.13562 | |
dc.identifier.uri | http://hdl.handle.net/10668/12731 | |
dc.issue.number | 1 | |
dc.journal.title | Allergy | |
dc.journal.titleabbreviation | Allergy | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Regional de Málaga | |
dc.organization | Instituto de Investigación Biomédica de Málaga-IBIMA | |
dc.page.number | 14-27 | |
dc.provenance | Realizada la curación de contenido 26/03/2025 | |
dc.publisher | Wiley | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Practice Guideline | |
dc.relation.publisherversion | https://doi.org/10.1111/all.13562 | |
dc.rights.accessRights | Restricted Access | |
dc.subject | Diagnosis | |
dc.subject | Drug Hypersensitivity | |
dc.subject | Classification | |
dc.subject | Diagnosis, Differential | |
dc.subject.decs | Diagnóstico Diferencial | |
dc.subject.decs | Piel | |
dc.subject.decs | Hipersensibilidad a las Drogas | |
dc.subject.decs | Clasificación | |
dc.subject.mesh | Drug Hypersensitivity | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Skin | |
dc.subject.mesh | Skin Diseases | |
dc.title | EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 74 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- RISalud_Accesorestringido.pdf
- Size:
- 93.39 KB
- Format:
- Adobe Portable Document Format